Antivirals used in combination for the treatment of HIV infections

All categories

DBCAT005506Pharmacologic classJ05AR

A DrugBank category of 21 drugs. 21 of them are approved.

ATC classification: J — ANTIINFECTIVES FOR SYSTEMIC USE
J05 — ANTIVIRALS FOR SYSTEMIC USE
J05A — DIRECT ACTING ANTIVIRALS
J05AR — Antivirals for treatment of HIV infections, combinations
Also known as: Antivirals for treatment of HIV infections, combinations · Antivirals used in combination to treat HIV infections · Drugs for treatment of HIV infections
Drugs: Abacavir
Atazanavir
Bictegravir
Cobicistat
Darunavir
Dolutegravir
Doravirine
Efavirenz
Elvitegravir
Emtricitabine
Lamivudine
Lenacapavir
Lopinavir
Nevirapine
Raltegravir
Rilpivirine
Ritonavir
Stavudine
Tenofovir alafenamide
Tenofovir disoproxil
Zidovudine

What you can answer from here — as of June 29, 2021

21DrugsEach linked to its full drug card

Listed above

24Drug targetsEvery drug–target pair in the class, with bond type

3,463Marketed productsAcross the regions we cover, with dosage forms and routes

6Routes of administrationHow the drugs in this class are given

Which targets do Antivirals used in combination for the treatment of HIV infections share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account